LEXX Projected Dividend Yield
Com Par $0.001 (New)/Lexaria Bioscience Corp ( NASDAQ : LEXX )Lexaria Bioscience is a biotechnology company pursuing the enhancement of the bioavailability of a range of active pharmaceutical ingredients (API) using its proprietary DehydraTECH drug delivery technology. Co.'s patent portfolio includes patent family applications or grants pertaining to Co.'s method of improving bioavailability and taste, and the use of DehydraTECH as a delivery platform for a variety of APIs encompassing all cannabinoids including tetrahydrocannabinol; fat soluble vitamins; non-steroidal anti-inflammatory drugs pain medications; and nicotine and its analogs. Co. has identified two reportable segments: Intellectual Property Licensing and B2B Production. 20 YEAR PERFORMANCE RESULTS |
LEXX Dividend History Detail LEXX Dividend News LEXX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |